Entry - %130020 - EHLERS-DANLOS SYNDROME, HYPERMOBILITY TYPE; EDSHMB - OMIM
% 130020

EHLERS-DANLOS SYNDROME, HYPERMOBILITY TYPE; EDSHMB


Alternative titles; symbols

EHLERS-DANLOS SYNDROME, TYPE III; EDS3
EDS III
BENIGN HYPERMOBILITY SYNDROME


Clinical Synopsis
 
Phenotypic Series
 

INHERITANCE
- Autosomal dominant
CARDIOVASCULAR
Heart
- Mitral valve prolapse
SKELETAL
- Joint hypermobility (large and small joints)
- Recurrent joint dislocations (shoulder, patella, temporomandibular joints)
- Osteoarthritis (onset 30-40 years)
SKIN, NAILS, & HAIR
Skin
- Soft skin
- Hyperextensible skin
- Sacral striae
- No scarring
MISCELLANEOUS
- Joint laxity decreases with age
- One patient reported with COL3A1 mutation (120180.0020)
MOLECULAR BASIS
- Caused by mutation in the tenascin XB gene (TNXB, 600985.0001)
Ehlers-Danlos syndrome - PS130000 - 23 Entries
Location Phenotype Inheritance Phenotype
mapping key
Phenotype
MIM number
Gene/Locus Gene/Locus
MIM number
1p36.33 Ehlers-Danlos syndrome, spondylodysplastic type, 2 AR 3 615349 B3GALT6 615291
1p36.22 Ehlers-Danlos syndrome, kyphoscoliotic type, 1 AR 3 225400 PLOD1 153454
2q32.2 Ehlers-Danlos syndrome, vascular type AD 3 130050 COL3A1 120180
2q32.2 Ehlers-Danlos syndrome, classic type, 2 AD 3 130010 COL5A2 120190
4q27 Brittle cornea syndrome 2 AR 3 614170 PRDM5 614161
5q35.3 Ehlers-Danlos syndrome, spondylodysplastic type, 1 AR 3 130070 B4GALT7 604327
5q35.3 Ehlers-Danlos syndrome, dermatosparaxis type AR 3 225410 ADAMTS2 604539
6p21.33-p21.32 Ehlers-Danlos syndrome, classic-like, 1 AR 3 606408 TNXB 600985
6q13-q14.1 Bethlem myopathy 2 AD 3 616471 COL12A1 120320
6q22.1 Ehlers-Danlos syndrome, musculocontractural type 2 AR 3 615539 DSE 605942
6q27 ?Ehlers-Danlos syndrome, classic-like, 3 AD 3 620865 THBS2 188061
7p14.3 Ehlers-Danlos syndrome, kyphoscoliotic type, 2 AR 3 614557 FKBP14 614505
7p13 Ehlers-Danlos syndrome, classic-like, 2 AR 3 618000 AEBP1 602981
7q21.3 Ehlers-Danlos syndrome, arthrochalasia type, 2 AD 3 617821 COL1A2 120160
7q21.3 Ehlers-Danlos syndrome, cardiac valvular type AR 3 225320 COL1A2 120160
9q34.3 Ehlers-Danlos syndrome, classic type, 1 AD 3 130000 COL5A1 120215
11p11.2 Ehlers-Danlos syndrome, spondylodysplastic type, 3 AR 3 612350 SLC39A13 608735
12p13.31 Ehlers-Danlos syndrome, periodontal type, 2 AD 3 617174 C1S 120580
12p13.31 Ehlers-Danlos syndrome, periodontal type, 1 AD 3 130080 C1R 613785
15q15.1 Ehlers-Danlos syndrome, musculocontractural type 1 AR 3 601776 CHST14 608429
16q24.2 Brittle cornea syndrome 1 AR 3 229200 ZNF469 612078
17q21.33 Ehlers-Danlos syndrome, arthrochalasia type, 1 AD 3 130060 COL1A1 120150
Not Mapped Ehlers-Danlos syndrome, hypermobility type AD 130020 EDSHMB 130020

TEXT

Description

The Ehlers-Danlos syndrome shows phenotypic and genetic heterogeneity; see 130000. Marked joint hyperextensibility without skeletal deformity dominates the clinical picture of hypermobility-type EDS. Skin manifestations are relatively inconspicuous. Differentiation from familial joint laxity (147900) is often uncertain.


Clinical Features

Wenstrup et al. (2002) performed a prospective cohort study on 71 consecutive EDS patients. Twenty of 71, or 28%, had aortic root dilatation defined as greater than 2 serum deviations above population-based norms. Fourteen of 42 individuals with the classic form of EDS (see 130000) and 6 of 29 individuals with the hypermobile form had aortic root dilatation, with no gender differences. Wenstrup et al. (2002) concluded that aortic root dilatation is a common finding in EDS. However, rates of progression and complication were unknown.

Castori et al. (2010) noted that there are more female than male patients with signs and symptoms of joint hypermobility. In a cohort of 38 well-characterized EDS hypermobility type index cases, 34 (89%) were female and 4 (11%) male. A positive family history was found for 9 probands, and among the affected relatives, 9 were female (69%) and 4 were male (31%), yielding a F:M sex ratio of 43 (84%): 8 (16%). Castori et al. (2010) postulated different mechanisms for the sex bias, including differential perception of muscle pain between men and women, greater joint stability in men, and hormonal changes in women. All of these biologic factors may work to explain the high gender bias in this disorder.


Other Features

Voermans et al. (2009) performed a cross-sectional study on the presence of neuromuscular symptoms among 40 patients with various forms of EDS. Ten patients each were analyzed with classic EDS (130000), vascular EDS (130050), hypermobility EDS, and TNX-deficient EDS (606408). Overall, those with classic EDS and TNX-deficient EDS reported the most neuromuscular involvement, with muscle weakness, hypotonia, myalgia, easy fatigability, and intermittent paresthesias, although patients in all groups reported these features. Physical examination showed mild to moderate muscle weakness (85%) and reduction of vibration sense (60%) across all groups. Nerve conduction studies demonstrated axonal polyneuropathy in 5 (13%) of 39 patients. Needle electromyography showed myopathic EMG features in 9 (26%) and a mixed neurogenic-myopathic pattern in 21 (60%) of 35 patients. Muscle ultrasound showed increased echo intensity in 19 (48%) and atrophy in 20 (50%) of 40 patients. Mild myopathic features were seen on muscle biopsy of 5 (28%) of 18 patients. Patients with the hypermobility type EDS caused by TNXB haploinsufficiency were least affected. Voermans et al. (2009) postulated that abnormalities in muscle or nerve extracellular matrix may underlie these findings.


Molecular Genetics

Narcisi et al. (1994) reported a family in which multiple members with a connective tissue disorder answering to the description of either EDS III or familial joint instability syndrome (147900) had a mutation in the COL3A1 gene (G637S; 120180.0020). Abnormalities in type III collagen are characteristic of EDS IV (130050); no features of that disorder, such as thin skin, typical facial features, or vascular fragility, were found in affected members of the family. The disorder in this family is here classified as a nonvascular variant of EDS IV.


See Also:

REFERENCES

  1. Beighton, P. The Ehlers-Danlos Syndrome. London: William Heinemann (pub.) 1970.

  2. Castori, M., Camerota, F., Celletti, C., Grammatico, P., Padua, L. Ehlers-Danlos syndrome hypermobility type and the excess of affected females: possible mechanisms and perspectives. Am. J. Med. Genet. 152A: 2406-2408, 2010. [PubMed: 20684008, related citations] [Full Text]

  3. Narcisi, P., Richards, A. J., Ferguson, S. D., Pope, F. M. A family with Ehlers-Danlos syndrome type III/articular hypermobility syndrome has a glycine 637-to-serine substitution in type III collagen. Hum. Molec. Genet. 3: 1617-1620, 1994. [PubMed: 7833919, related citations] [Full Text]

  4. Voermans, N. C., van Alfen, N., Pillen, S., Lammens, M., Schalkwijk, J., Zwarts, M. J., van Rooij, I. A., Hamel, B. C. J., van Engelen, B. G. Neuromuscular involvement in various types of Ehlers-Danlos syndrome. Ann. Neurol. 65: 687-697, 2009. [PubMed: 19557868, related citations] [Full Text]

  5. Wenstrup, R. J., Meyer, R. A., Lyle, J. S., Hoechstetter, L., Rose, P. S., Levy, H. P., Francomano, C. A. Prevalence of aortic root dilation in the Ehlers-Danlos syndrome. Genet. Med. 4: 112-117, 2002. [PubMed: 12180144, related citations] [Full Text]


Cassandra L. Kniffin - updated : 6/15/2011
Cassandra L. Kniffin - updated : 11/19/2009
Cassandra L. Kniffin - updated : 4/1/2005
Victor A. McKusick - updated : 6/25/2003
Ada Hamosh - updated : 3/6/2003
Victor A. McKusick - updated : 10/13/1999
Creation Date:
Victor A. McKusick : 6/4/1986
carol : 12/22/2017
carol : 12/21/2017
carol : 11/30/2015
carol : 4/13/2015
carol : 4/13/2015
wwang : 6/29/2011
ckniffin : 6/15/2011
wwang : 2/17/2010
carol : 1/21/2010
ckniffin : 11/19/2009
carol : 11/21/2008
carol : 3/15/2007
carol : 4/22/2005
ckniffin : 4/1/2005
carol : 12/3/2003
tkritzer : 7/17/2003
tkritzer : 7/14/2003
terry : 6/25/2003
carol : 4/4/2003
cwells : 3/6/2003
mcapotos : 7/5/2001
mgross : 10/15/1999
terry : 10/13/1999
carol : 11/13/1998
alopez : 9/10/1998
mark : 9/16/1997
terry : 11/16/1994
mimadm : 9/24/1994
carol : 10/19/1992
supermim : 3/16/1992
supermim : 3/20/1990
ddp : 10/26/1989

% 130020

EHLERS-DANLOS SYNDROME, HYPERMOBILITY TYPE; EDSHMB


Alternative titles; symbols

EHLERS-DANLOS SYNDROME, TYPE III; EDS3
EDS III
BENIGN HYPERMOBILITY SYNDROME


SNOMEDCT: 30652003;   ICD10CM: Q79.62;   ORPHA: 285;   DO: 14757;  



TEXT

Description

The Ehlers-Danlos syndrome shows phenotypic and genetic heterogeneity; see 130000. Marked joint hyperextensibility without skeletal deformity dominates the clinical picture of hypermobility-type EDS. Skin manifestations are relatively inconspicuous. Differentiation from familial joint laxity (147900) is often uncertain.


Clinical Features

Wenstrup et al. (2002) performed a prospective cohort study on 71 consecutive EDS patients. Twenty of 71, or 28%, had aortic root dilatation defined as greater than 2 serum deviations above population-based norms. Fourteen of 42 individuals with the classic form of EDS (see 130000) and 6 of 29 individuals with the hypermobile form had aortic root dilatation, with no gender differences. Wenstrup et al. (2002) concluded that aortic root dilatation is a common finding in EDS. However, rates of progression and complication were unknown.

Castori et al. (2010) noted that there are more female than male patients with signs and symptoms of joint hypermobility. In a cohort of 38 well-characterized EDS hypermobility type index cases, 34 (89%) were female and 4 (11%) male. A positive family history was found for 9 probands, and among the affected relatives, 9 were female (69%) and 4 were male (31%), yielding a F:M sex ratio of 43 (84%): 8 (16%). Castori et al. (2010) postulated different mechanisms for the sex bias, including differential perception of muscle pain between men and women, greater joint stability in men, and hormonal changes in women. All of these biologic factors may work to explain the high gender bias in this disorder.


Other Features

Voermans et al. (2009) performed a cross-sectional study on the presence of neuromuscular symptoms among 40 patients with various forms of EDS. Ten patients each were analyzed with classic EDS (130000), vascular EDS (130050), hypermobility EDS, and TNX-deficient EDS (606408). Overall, those with classic EDS and TNX-deficient EDS reported the most neuromuscular involvement, with muscle weakness, hypotonia, myalgia, easy fatigability, and intermittent paresthesias, although patients in all groups reported these features. Physical examination showed mild to moderate muscle weakness (85%) and reduction of vibration sense (60%) across all groups. Nerve conduction studies demonstrated axonal polyneuropathy in 5 (13%) of 39 patients. Needle electromyography showed myopathic EMG features in 9 (26%) and a mixed neurogenic-myopathic pattern in 21 (60%) of 35 patients. Muscle ultrasound showed increased echo intensity in 19 (48%) and atrophy in 20 (50%) of 40 patients. Mild myopathic features were seen on muscle biopsy of 5 (28%) of 18 patients. Patients with the hypermobility type EDS caused by TNXB haploinsufficiency were least affected. Voermans et al. (2009) postulated that abnormalities in muscle or nerve extracellular matrix may underlie these findings.


Molecular Genetics

Narcisi et al. (1994) reported a family in which multiple members with a connective tissue disorder answering to the description of either EDS III or familial joint instability syndrome (147900) had a mutation in the COL3A1 gene (G637S; 120180.0020). Abnormalities in type III collagen are characteristic of EDS IV (130050); no features of that disorder, such as thin skin, typical facial features, or vascular fragility, were found in affected members of the family. The disorder in this family is here classified as a nonvascular variant of EDS IV.


See Also:

Beighton (1970)

REFERENCES

  1. Beighton, P. The Ehlers-Danlos Syndrome. London: William Heinemann (pub.) 1970.

  2. Castori, M., Camerota, F., Celletti, C., Grammatico, P., Padua, L. Ehlers-Danlos syndrome hypermobility type and the excess of affected females: possible mechanisms and perspectives. Am. J. Med. Genet. 152A: 2406-2408, 2010. [PubMed: 20684008] [Full Text: https://doi.org/10.1002/ajmg.a.33585]

  3. Narcisi, P., Richards, A. J., Ferguson, S. D., Pope, F. M. A family with Ehlers-Danlos syndrome type III/articular hypermobility syndrome has a glycine 637-to-serine substitution in type III collagen. Hum. Molec. Genet. 3: 1617-1620, 1994. [PubMed: 7833919] [Full Text: https://doi.org/10.1093/hmg/3.9.1617]

  4. Voermans, N. C., van Alfen, N., Pillen, S., Lammens, M., Schalkwijk, J., Zwarts, M. J., van Rooij, I. A., Hamel, B. C. J., van Engelen, B. G. Neuromuscular involvement in various types of Ehlers-Danlos syndrome. Ann. Neurol. 65: 687-697, 2009. [PubMed: 19557868] [Full Text: https://doi.org/10.1002/ana.21643]

  5. Wenstrup, R. J., Meyer, R. A., Lyle, J. S., Hoechstetter, L., Rose, P. S., Levy, H. P., Francomano, C. A. Prevalence of aortic root dilation in the Ehlers-Danlos syndrome. Genet. Med. 4: 112-117, 2002. [PubMed: 12180144] [Full Text: https://doi.org/10.1097/00125817-200205000-00003]


Contributors:
Cassandra L. Kniffin - updated : 6/15/2011
Cassandra L. Kniffin - updated : 11/19/2009
Cassandra L. Kniffin - updated : 4/1/2005
Victor A. McKusick - updated : 6/25/2003
Ada Hamosh - updated : 3/6/2003
Victor A. McKusick - updated : 10/13/1999

Creation Date:
Victor A. McKusick : 6/4/1986

Edit History:
carol : 12/22/2017
carol : 12/21/2017
carol : 11/30/2015
carol : 4/13/2015
carol : 4/13/2015
wwang : 6/29/2011
ckniffin : 6/15/2011
wwang : 2/17/2010
carol : 1/21/2010
ckniffin : 11/19/2009
carol : 11/21/2008
carol : 3/15/2007
carol : 4/22/2005
ckniffin : 4/1/2005
carol : 12/3/2003
tkritzer : 7/17/2003
tkritzer : 7/14/2003
terry : 6/25/2003
carol : 4/4/2003
cwells : 3/6/2003
mcapotos : 7/5/2001
mgross : 10/15/1999
terry : 10/13/1999
carol : 11/13/1998
alopez : 9/10/1998
mark : 9/16/1997
terry : 11/16/1994
mimadm : 9/24/1994
carol : 10/19/1992
supermim : 3/16/1992
supermim : 3/20/1990
ddp : 10/26/1989